Wednesday, June 3, 2015

BMJ - TMP-SMX v. Vanco for MRSA

"Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by met[h]icillin resistant Staphylococcus aureus: randomised controlled trial"

"Conclusions High dose trimethoprim-sulfamethoxazole did not achieve non-inferiority to vancomycin in the treatment of severe MRSA infections. The difference was particularly marked for patients with bacteraemia."

http://www.bmj.com/content/350/bmj.h2219

No comments:

Post a Comment